Calendar

Events that a source expects, grouped by the month, quarter or half-year the source names, with who expected each and when they said so.

Upcoming as of , the date this release was built (the newest input commit date), not today's date. An expected date is a statement by the source, not a result, and it can move. Dated events are on the timeline.

8,817 of these dates come from registry records: the start, primary completion or completion that a registry expects of a trial. A program assembled them, and a registry often leaves a date unchanged after it has passed. The calendar file lists the dates of written pages only.

Add to your calendar (calendar.ics)

The calendar file has one all-day event for each upcoming item. Where a source gives only a month, a quarter, a half-year or a year, the event sits on the first day of that period and its title says "expected sometime in" the period.

Upcoming

April 2028 61

  1. Study completion RDN for CKD and Uncontrolled Hypertension Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07945795

May 2028 69

  1. Primary completion Inhaled Milrinone and Epoprostenol for the Prevention of Difficult Cardiac Pulmonary Bypass Separation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05450328

  2. Primary completion Conscious Sedation Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06049615

  3. Primary completion Efficacy and Safety of Oral Controlled-release Nicotinic Acid (CIR-NA) for the Remission of Prediabetes. (CONCEPT) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07286747

  4. Study completion A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07754461

  5. Study completion Clinical Surveillance vs. Anticoagulation for Low-risk Patients With Isolated Subsegmental Pulmonary Embolism Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04263038

  6. Primary completion Clinical Surveillance vs. Anticoagulation for Low-risk Patients With Isolated Subsegmental Pulmonary Embolism Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04263038

  7. Primary completion Extending the Time Window for Tenecteplase by Recanalization of Basilar Artery Occlusion in Posterior Circulation Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05105633

  8. Study completion Semaglutide to Reduce Atrial Fibrillation Burden Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05209165

  9. Study completion Rituximab in Patients With ST-elevation Myocardial Infarction Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05211401

  10. Study completion Transcatheter Mitral Valve Repair for Inotrope Dependent Cardiogenic Shock Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05298124

  11. Primary completion Transcatheter Mitral Valve Repair for Inotrope Dependent Cardiogenic Shock Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05298124

  12. Primary completion Successfully Achieving and Maintaining Euglycemia During Pregnancy for Type 2 Diabetes Through Technology and Coaching Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05662462

  13. Study completion Clinical Outcomes of CT-FFR Versus QFR-guided Strategy for Decision-Making in Patients With Stable Chest Pain Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05857904

  14. Primary completion Physiologic Cardiac Pacing to Prevent Left Ventricular Dysfunction Post TAVI Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05966675

  15. Study completion Prehospital Resuscitation Intranasal Cooling Effectiveness Survival Study 2 Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06025123

  16. Study completion Anti-inflammatory and Anti-thrombotic Therapy With colcHicine and Low Dose Rivaroxaban for Major Adverse Cardiovascular Events Reduction in Ischemic Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06396858

  17. Study completion Post Market Study for VasQ, an External Support Implant for Arteriovenous Fistula Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06516653

  18. Study completion Jockey Club Precision Prevention Programme on Young Onset Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06693934

  19. Primary completion The European Bifurcation Club Randomized Trial of Stepwise Provisional Stenting Versus Drug Coated Balloon Therapy for Non-left Main True Coronary Bifurcations Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06822322

  20. Study completion ASCEND CSP IDE Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06830746

  21. Primary completion Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06911632

  22. Primary completion Renal Artery Denervation Assessment Without Antihypertensive Medication Regimen (RADAR) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07083765

  23. Study completion CAPTURE-2: Controlled Arterial Protection to Ultimately Remove Embolic Material Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07276711

  24. Primary completion CAPTURE-2: Controlled Arterial Protection to Ultimately Remove Embolic Material Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07276711

  25. Study completion Conduction System Pacing and AV Junction Ablation in Heart Failure With Atrial Fibrillation (SYNC AF-HTx) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07332871

  26. Study completion Effect of Intravenous Iron on Quality of Life in Older Patients With Acute Coronary Syndrome Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07476859

  27. Study completion Vortosiran for VTE Prevention Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07850453

  28. Primary completion A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07595549

  29. Study completion Predictive Value of Glycemic Parameters Measured With the FSL Pro iQ During ACS Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06014112

  30. Primary completion Predictive Value of Glycemic Parameters Measured With the FSL Pro iQ During ACS Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06014112

  31. Primary completion A Study to Learn About the Study Medicine Called PF-07328948 in Adults With Heart Failure (BRANCH-HF) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06991257

  32. Primary completion Signos DM2 Empowerment Study (SIGNOS-CGM-EMPOWER-201-2022) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05874635

  33. Study completion Open-Label Safety Study of Acoramidis (AG10) in Symptomatic ATTR Participants Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04988386

  34. Study completion Hypertonic Lactate After Cardiac Arrest Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05004610

  35. Study completion Safety and Efficacy of Mesenchymal Stromal Cells (Amimestrocel ) in Diabetic Kidney Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06969807

  36. Study completion A Study to Learn About the Study Medicine (PF-08653944) in People With Obesity or Overweight and Type 2 Diabetes (T2D) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07400653

  37. Study completion MOTS-c for Improving Insulin Sensitivity in Adults With Prediabetes and Overweight/Obesity Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07505745

  38. Study completion Recombinant Human Thymosin Beta 4 for Injection(NL005) for Acute Myocardial Infarction Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07586865

  39. Primary completion Reperfusion Approach in Predicted In-hospital Delay for Primary PCI in STEMI Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07641231

  40. Study completion Evolocumab or Normal Strategies to Reach LDL Objectives in Acute Myocardial Infarction Upbound to PCI Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04951856

  41. Study completion A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06424288

  42. Primary completion A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06424288

  43. Study completion A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus on Background Insulin Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07664553

  44. Primary completion A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus on Background Insulin Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07664553

  45. Study completion The Value of IVL Compared To OPN Non-Compliant Balloons for Treatment of RefractorY Coronary Lesions (VICTORY) Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05346068

  46. Study completion Adjunctive Intra-arterial Tenecteplase Following Mechanical Thrombectomy (ALLY) II Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06949228

  47. Primary completion Adjunctive Intra-arterial Tenecteplase Following Mechanical Thrombectomy (ALLY) II Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06949228

  48. Study completion Hyperpolarized MR Imaging With Carbon-13 Pyruvate in the Human Body Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06645691

  49. Primary completion Hyperpolarized MR Imaging With Carbon-13 Pyruvate in the Human Body Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06645691

  50. Primary completion Transfemoral TAVI With or Without Coronary Angiogram in Patients With Severe Aortic Stenosis (PURE TAVI) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06898086

  51. Study completion Monitoring Hyperkalemia Using Point-of-care AI-enabled ECG Device Among Patients With Chronic Kidney Disease Stages 3b-5 Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06901960

  52. Study completion Study to Evaluate the Impact of a Targeted Lipid Optimization Program on LDL-C Control in At-risk Adult Patients With Dyslipidemia Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07034690

  53. Primary completion A Study Evaluating the Effectiveness and Safety of Pulsed Field Ablation Using the FARAPULSE™ System for Electrical Isolation of Pulmonary Veins and Superior Vena Cava Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07162597

  54. Study completion Tenecteplase vs Medical Management in 4.5-24h LVO no Access to EVT Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07168278

  55. Primary completion Real-time Continuous Glucose Monitoring Compared With Intermittent Continuous Glucose Monitoring in People With Type 2 Diabetes Treated With Insulin. Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07308925

  56. Study completion A Study of VARIPULSE Pulsed Field Ablation (PFA) Catheter and FARAWAVE PFA Catheter in the Treatment of Participants With Persistent Atrial Fibrillation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07523750

  57. Primary completion A Study of VARIPULSE Pulsed Field Ablation (PFA) Catheter and FARAWAVE PFA Catheter in the Treatment of Participants With Persistent Atrial Fibrillation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07523750

  58. Primary completion A Phase 3 Study of Extended-release Tacrolimus in Subjects With Pulmonary Arterial Hypertension and Functional Limitations Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07612657

  59. Study completion Efficacy of Verciguat in TR and RV Failure Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07668739

  60. Primary completion Efficacy of Verciguat in TR and RV Failure Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07668739

  61. Study completion Ciprofol vs Propofol for Hemodynamic Stability in Patients Having General Anesthesia for Endovascular Thrombectomy After Ischemic Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07696208

  62. Primary completion Tirzepatide in Thrombectomy-Treated Acute Ischemic Stroke: A Randomized Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07734792

  63. Primary completion Utility of the Perclose ProGlide™ Suture-Mediated Closure Device After Cardiologic Procedures Via the Femoral Vein Approach (Eight-Clover) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07827287

June 2028 116

  1. Primary completion Balloon vs. Self Expanding Transcatheter Valve for Degenerated Bioprosthesis Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04843072

  2. Primary completion Impact of Intensive Treatment of SBP on Brain Perfusion, Amyloid, and Tau (IPAT Study) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05331144

  3. Study completion A Study on the Effects of Left Ventricular Unloading in the Setting of VA ECMO Support Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05913622

  4. Study completion Neurovascular Regulation During Exercise in Humans With Chronic Kidney Disease: Sympatholysis in CKD Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05928936

  5. Primary completion Neurovascular Regulation During Exercise in Humans With Chronic Kidney Disease: Sympatholysis in CKD Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05928936

  6. Study completion Early Initiation of Tafolecimab for Patients With Acute Coronary Syndromeundergoing Percutaneous Coronary Intervention in Chinese Population Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06096909

  7. Study completion A Study of Angiotensin-II Receptor Blocker on Cardiovascular Remodeling (VALUE Trial) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06150560

  8. Primary completion A Study of Angiotensin-II Receptor Blocker on Cardiovascular Remodeling (VALUE Trial) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06150560

  9. Primary completion Non-immunogenic Recombinant Staphylokinase vs Placebo in Patients With Intermediate High-risk Pulmonary Embolism Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06362746

  10. Primary completion LDL-C Optimization Using Inclisiran in Patients in Which Drug-Drug Interactions Limit LDL Lowering Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06865885

  11. Study completion Metformin Alleviates Abnormal Glucose Metabolism Induced by Statins in Schizophrenia Patients Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07045142

  12. Study completion Foundation Model for Post-MI Cardiovascular Event Alert Using Huawei Watch Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07395648

  13. Primary completion A Study of Bempedoic Acid/Ezetimibe/High-intensity Statin in Patients Without Cardiovascular Events Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07474649

  14. Study completion Effect of the Traditional Chinese Medicine Yufeng Ningxin in Patients With Hypertension Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07607275

  15. Primary completion Naoxintong Capsule for Diabetic Nephropathy With Dampness Retention Pattern: A Multicenter, Randomized, Double-Blind, Placebo-Controlled TrialAcronymNXT-DKD Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07698223

  16. Primary completion Ezetimibe for Arrhythmia Recurrence After AF Ablation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07752758

  17. Primary completion Importance of Point-of-Care Ultrasound for Early Detection of Valvular and Cardiac Diseases (IMPROVE) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07756398

  18. Study completion Capitalizing on AI to CapTure Undiagnosed Structural Heart Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07843004

  19. Primary completion The OXY-VENT Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07870551

  20. Study completion Synbiotic as an Adjuvant Therapy for Dyslipidaemia and Gut Health Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07915687

  21. Primary completion A Research Study to Investigate How Well the Medicine CagriSema Lowers High Blood Pressure in People Living With High Blood Pressure and Obesity Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07919405

  22. Study completion Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Transcatheter Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03433274

  23. Study completion Distal Evaluation of Functional Performance with Intravascular Sensors to Assess the Narrowing Effect: Guided Physiologic Stenting Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04451044

  24. Study completion PrizValve® Transcatheter Aortic Valve Replacement Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04836897

  25. Primary completion The CONFORM Pivotal Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05147792

  26. Study completion To Compare the Efficacy and Safety of the ATEV With AVF in Female Patients With End-Stage Renal Disease Requiring Hemodialysis Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05908084

  27. Study completion Physiologic Cardiac Pacing to Prevent Left Ventricular Dysfunction Post TAVI Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05966675

  28. Study completion Effect of Endoscopic Sleeve Gastroplasty in Patients With Obesity and MASH: A Randomized Controlled Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06138821

  29. Primary completion Atrial Fibrillation Ablation Versus Atrioventricular Nodal Ablation with Conduction System Pacing in Heart Failure Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06207383

  30. Study completion PIvotal Trial of the KARDION Cory P4 MechANical Circulatory SupporT SystEm Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06445608

Overdue

The expected date has passed and no published record says the event happened. This does not mean it failed or was delayed: the atlas may not have checked the source since. Oldest first.

  1. Primary completion Clinical Trial of C-Wave™ Peripheral Lithoclasty System Catheter System Registry record

    Expected 2023-09-08; that period ended on 2023-09-08.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05435716

  2. Study completion TReAtmeNt of Small Coronary Vessels: MagicTouch Sirolimus Coated Balloon Registry record

    Expected 2023-09-10; that period ended on 2023-09-10.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03913832

  3. Primary completion Thrombolysis Combined With Edaravone Dexborneol on Hemorrhagic Transformation for Acute Ischemic Stroke Registry record

    Expected 2023-09-13; that period ended on 2023-09-13.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05035953

  4. Study completion Intracoronary of Nicorandil and Verapamil to Reduce the Occurrence of Periprocedural Myocardial Injury Registry record

    Expected 2023-09-17; that period ended on 2023-09-17.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05399576

  5. Primary completion The Application of a Wireless Sensor Technology for Vital Statistics in CHILDREN AND ADULTS Registry record

    Expected 2023-09; that period ended on 2023-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01845506

  6. Study completion Sizing-sTrategy of Bicuspid AoRtic Valve Stenosis With Transcatheter Self-expandable Valve Registry record

    Expected 2023-09; that period ended on 2023-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02541877

  7. Primary completion The Effects of Early and Late Injection of Botulinum Toxin Type A on Upper Limb Function in Patients With Stroke Registry record

    Expected 2023-09; that period ended on 2023-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02580838

  8. Study completion Left Chamber Function in Mitral Regurgitation and Predicting Outcome After Replacement and Targeting for Early Surgery Registry record

    Expected 2023-09; that period ended on 2023-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03870516

  9. Primary completion Left Chamber Function in Mitral Regurgitation and Predicting Outcome After Replacement and Targeting for Early Surgery Registry record

    Expected 2023-09; that period ended on 2023-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03870516

  10. Study completion Remote Magnetic Versus Manual Navigation-guided Ablation for Non-outflow Tract Premature Ventricular Contractions: a Prospective, Randomized, Controlled Trial Registry record

    Expected 2023-09-30; that period ended on 2023-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04519112

  11. Study start Air Pollution (PM2.5) on Accelerated Atherosclerosis: A Montelukast Interventional Study in Modernizing China Registry record

    Expected 2023-09; that period ended on 2023-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04762472

  12. Study completion Suxiao Jiuxin Pills in Microvascular Obstruction in Patients With Acute Coronary Syndrome Registry record

    Expected 2023-09-30; that period ended on 2023-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04814121

  13. Primary completion Suxiao Jiuxin Pills in Microvascular Obstruction in Patients With Acute Coronary Syndrome Registry record

    Expected 2023-09-30; that period ended on 2023-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04814121

  14. Study completion Henagliflozin in Patients With Atrial Fibrillation Registry record

    Expected 2023-09-30; that period ended on 2023-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05252624

  15. Primary completion Henagliflozin in Patients With Atrial Fibrillation Registry record

    Expected 2023-09-30; that period ended on 2023-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05252624

  16. Primary completion Dengzhanxixin Injection for Acute Ischemic Stroke Receiving Reperfusion Therapy Registry record

    Expected 2023-09-30; that period ended on 2023-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05700097

  17. Study completion Thoracoscopic Ablation for Lone Atrial Fibrillation Registry record

    Expected 2023-09-30; that period ended on 2023-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05708027

  18. Study completion Once Versus Twice Bisoprolol Dosage Regimen in Prevention of Atrial Fibrillation Post Coronary Artery Bypass Graft Surgery Registry record

    Expected 2023-09; that period ended on 2023-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05730413

  19. Primary completion Once Versus Twice Bisoprolol Dosage Regimen in Prevention of Atrial Fibrillation Post Coronary Artery Bypass Graft Surgery Registry record

    Expected 2023-09; that period ended on 2023-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05730413

  20. Study start Dutogliptin in Co-administration With Filgrastim in Early Recovery Post-myocardial Infarction Registry record

    Expected 2023-09; that period ended on 2023-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05881382

  21. Study completion Long-term Clinical Outcomes of intraVascular Ultrasound-guided vs Angiography-guided Primary pErcutaneous Intervention in Patients With Acute ST Segment Elevated Myocardial Infarction Registry record

    Expected 2023-10-01; that period ended on 2023-10-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04063345

  22. Primary completion Multi-lead ECG to Effectively Optimize Resynchronization Devices: New CRT Recipients Registry record

    Expected 2023-10-01; that period ended on 2023-10-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04083690

  23. Study start Unloading in Heart Failure Cardiogenic Shock Registry record

    Expected 2023-10-01; that period ended on 2023-10-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05064202

  24. Study completion Efficacy and Safety Study of the Fixed-dose Combination of Olmesartan + Indapamide When Compared to the Isolated Drugs in the Treatment of Hypertension. Registry record

    Expected 2023-10-01; that period ended on 2023-10-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05110898

  25. Study completion The Efficacy and Safety of Different Doses of SY-009 in Patients With Type 2 Diabetes Mellitus Registry record

    Expected 2023-10-01; that period ended on 2023-10-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05426018

  26. Study start Prophylactic Frequent Premature Ventricular complexeS sUPPression on Left ventriculaR Function impairmEnt in aSymptomatic patientS Registry record

    Expected 2023-10-01; that period ended on 2023-10-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05784051

  27. Study start Effect of Spironolactone in the Prevention of Anthracycline-induced Cardiotoxicity (SPIROTOX) Registry record

    Expected 2023-10-01; that period ended on 2023-10-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06005259

  28. Study start Subcutaneous Cardiac Monitoring of Patients With BTK Inhibitors Registry record

    Expected 2023-10-01; that period ended on 2023-10-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06029166

  29. Primary completion Telemonitoring Program in the Vulnerable Phase After Hospitalization for Heart Failure Registry record

    Expected 2023-10-07; that period ended on 2023-10-07.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05972746

  30. Study completion Efficacy and Safety of Dexmedetomidine in the Analgesic Prophylaxis , in Patients Undergoing Cardiovascular Surgery Registry record

    Expected 2023-10-10; that period ended on 2023-10-10.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05079672

  31. Primary completion Clinical Of Plain Balloon Dilatation Combined Stent Versus Endovascular Debulking Combined Drug-coated Balloon to Treat Arteriosclerosis Occlusive Disease of Lower Extremity Registry record

    Expected 2023-10-10; that period ended on 2023-10-10.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05158257

  32. Study start The Effect of Early Administration of PCSK9 Inhibitor to Acute Ischemic Stroke Patients Associated With Atherosclerosis on the Stroke Prognosis and Lipid Profile Registry record

    Expected 2023-10-15; that period ended on 2023-10-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06083961

  33. Primary completion Non-adhesive Liquid Embolic System in the Embolization of Cerebral Arteriovenous Malformations Registry record

    Expected 2023-10-17; that period ended on 2023-10-17.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05058482

  34. Study completion Renal HEIR Study: Renal Hemodynamics, Energetics and Insulin Resistance in Youth Onset Type 2 Diabetes Study Registry record

    Expected 2023-10-30; that period ended on 2023-10-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03584217

  35. Study completion Intensive Medical Therapy for High-risk Intracranial or Extracranial Atherosclerosis Registry record

    Expected 2023-10-30; that period ended on 2023-10-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03635749

  36. Study completion Endovascular Treatment and RIPC in Acute Ischemic Stroke Registry record

    Expected 2023-10-30; that period ended on 2023-10-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04581759

  37. Primary completion Prediabetes Management Registry record

    Expected 2023-10-30; that period ended on 2023-10-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05531838

  38. Study completion Comparison of Losartan Associated With Indapamide Versus Hyzaar® in the Hypertension Treatment Registry record

    Expected 2023-10; that period ended on 2023-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01620788

  39. Study completion Does the Advice to Eat a Mediterranean Diet With Low Carbohydrate Intake, Compared With a Low-fat Diet, Reduce Diabetes and Cardiovascular Disease? Registry record

    Expected 2023-10; that period ended on 2023-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02938832

  40. Study completion Robot-Enhanced Stroke Therapy Optimizes Rehabilitation (RESTORE) Registry record

    Expected 2023-10; that period ended on 2023-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04201613

  41. Primary completion Cysteinyl Leukotriene Antagonist in Atherosclerosis Inhibition in Patients After Endovascular Treatment Due to Peripheral Arterial Disease Registry record

    Expected 2023-10; that period ended on 2023-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04277702

  42. Primary completion A Digital Solution for Patients With Heart Failure Registry record

    Expected 2023-10-31; that period ended on 2023-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05193344

  43. Primary completion To Evaluate the Efficacy and Safety of JT-003 add-on in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin and Dapagliflozin Registry record

    Expected 2023-10-31; that period ended on 2023-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05296044

  44. Primary completion The Effect of Glimepiride Compared With Sitagliptin as an add-on Therapy to Metformin in Severe Insulin Deficiency Diabetes Registry record

    Expected 2023-10-31; that period ended on 2023-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05386186

  45. Primary completion Safety Study of Intracranial Support Catheter and Guide Catheter for Stent-Assisted Embolization in the Treatment of Intracranial Aneurysms Registry record

    Expected 2023-10; that period ended on 2023-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05524285

  46. Study completion Clinical Trial to Evaluate the Efficacy and Safety of D064 and D701 Combination Therapy Registry record

    Expected 2023-10; that period ended on 2023-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05526703

  47. Primary completion Clinical Trial to Evaluate the Efficacy and Safety of D064 and D701 Combination Therapy Registry record

    Expected 2023-10; that period ended on 2023-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05526703

  48. Study start A Prospective Multicenter Pivotal Study to Evaluate Safety and Effectiveness of Venus-Neo Surgical Aortic Valve Registry record

    Expected 2023-10-31; that period ended on 2023-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05941455

  49. Study start Venus-Vitae Pivotal Study Smart-Align Study Registry record

    Expected 2023-10-31; that period ended on 2023-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05991271

  50. Study start Tongxinluo Capsule in the Treatment of Cerebral Small Vessel Disease-A Randomized, Double-blind, Placebo-controlled, Multicenter Clinical Study(TOPS-CSVD) Registry record

    Expected 2023-10; that period ended on 2023-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06061692

  51. Primary completion Ferumoxytol-enhanced Magnetic Resonance Imaging Registry record

    Expected 2023-11-01; that period ended on 2023-11-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02954510

  52. Study completion Hemoglobin Maintenance in Pediatric ESRD (End-stage Renal Disease) Patients by Ferric Pyrophosphate Citrate (FPC) Registry record

    Expected 2023-11-01; that period ended on 2023-11-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04239391

  53. Primary completion Landiolol for Prevention of Postoperative Atrial Fibrillation in Patients Undergoing Cardiac Surgery Registry record

    Expected 2023-11-01; that period ended on 2023-11-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05084118

  54. Primary completion Olive Leaf Extracts in the Control of Cardiovascular Risk Registry record

    Expected 2023-11-01; that period ended on 2023-11-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05297110

  55. Study completion A Study of TG103 Injection in Type 2 Diabetes Subjects Registry record

    Expected 2023-11-01; that period ended on 2023-11-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05348122

  56. Primary completion A Study of TG103 Injection in Type 2 Diabetes Subjects Registry record

    Expected 2023-11-01; that period ended on 2023-11-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05348122

  57. Study completion ECG Validation Study Registry record

    Expected 2023-11-01; that period ended on 2023-11-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05445726

  58. Study start Effect of Dexamethason on Postimplantation Syndrome After EVAR Registry record

    Expected 2023-11-01; that period ended on 2023-11-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06044480

  59. Primary completion Thrombolysis Treated With TNK-tPA in Acute Ischemic Stroke Patients (3T Stroke-Ⅲ) Registry record

    Expected 2023-11-04; that period ended on 2023-11-04.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05745259

  60. Study completion Telemonitoring Program in the Vulnerable Phase After Hospitalization for Heart Failure Registry record

    Expected 2023-11-07; that period ended on 2023-11-07.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05972746

  61. Study completion Effect of Oral Anti-diabetic Medication on Liver Fat in Subjects With Type II Diabetes and Non-alcoholic Fatty Liver Registry record

    Expected 2023-11-15; that period ended on 2023-11-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04976283

  62. Primary completion PRospective Evaluation of Complete Revascularization in Patients With multiveSsel Disease Excluding chroNic Total Occlusions Registry record

    Expected 2023-11-18; that period ended on 2023-11-18.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05230446

  63. Primary completion Non-elastic Compression Garment Therapy Versus Control for Deep Vein Thrombosis Registry record

    Expected 2023-11-30; that period ended on 2023-11-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03368313

  64. Study completion Intracavitary Injection of hUMSCs in Acute Basal Ganglia Hematoma After Stereotactic Aspiration Registry record

    Expected 2023-11; that period ended on 2023-11-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04074408

  65. Study completion Implementing Precision Medicine Approaches to Guide Anti-platelet Selection Registry record

    Expected 2023-11-30; that period ended on 2023-11-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04090281

  66. Study completion ROtational Atherectomy, Lithotripsy or LasER for the Treatment of CAlcified STEnosis Registry record

    Expected 2023-11; that period ended on 2023-11-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04181268

  67. Primary completion ROtational Atherectomy, Lithotripsy or LasER for the Treatment of CAlcified STEnosis Registry record

    Expected 2023-11; that period ended on 2023-11-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04181268

  68. Study completion Laser Acupuncture Improves Constipation in Patients Hospitalized for Stroke During the COVID-19 Pandemic Registry record

    Expected 2023-11-30; that period ended on 2023-11-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05002348

  69. Primary completion Laser Acupuncture Improves Constipation in Patients Hospitalized for Stroke During the COVID-19 Pandemic Registry record

    Expected 2023-11-30; that period ended on 2023-11-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05002348

  70. Study completion Long-term Efficacy of Drug-coated Balloon Versus Drug-eluting Stent in Large de Novo Coronary Lesions Registry record

    Expected 2023-11; that period ended on 2023-11-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05101005

  71. Primary completion Long-term Efficacy of Drug-coated Balloon Versus Drug-eluting Stent in Large de Novo Coronary Lesions Registry record

    Expected 2023-11; that period ended on 2023-11-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05101005

  72. Primary completion Study to Evaluate the Safety and Efficacy of PB-201 in Treatment-naive Patients With Type 2 Diabetes Mellitus Registry record

    Expected 2023-11; that period ended on 2023-11-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05102149

  73. Primary completion Use of Colchicine to Decrease Atrial Fibrillation Recurrence After Ablation Registry record

    Expected 2023-11-30; that period ended on 2023-11-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05459974

  74. Primary completion Efficacy and Safety of Sarecycline in Patients With Acute Ischemic Stroke After Reperfusion Therapy Registry record

    Expected 2023-11; that period ended on 2023-11-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05836753

  75. Study start Clinical Study on the Noninvasive Lung Fluid Monitoring System in Guiding the Treatment of Heart Failure Registry record

    Expected 2023-11; that period ended on 2023-11-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06102031

  76. Study start EFfects of Y-6 SUblingual Tablets foR PaTients With AcUte Ischemic StRokE (FUTURE) Registry record

    Expected 2023-11; that period ended on 2023-11-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06138834

  77. Study completion Myocardial Work and Metabolism in CRT Registry record

    Expected 2023-12-01; that period ended on 2023-12-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02537782

  78. Primary completion Screening for Cancer in Patients With Unprovoked VTE Registry record

    Expected 2023-12-01; that period ended on 2023-12-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03937583

  79. Primary completion TROPHY PAH Pivotal Study - TReatment of Pulmonary HYpertension for PAH Pivotal Study Registry record

    Expected 2023-12-01; that period ended on 2023-12-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04570228

  80. Primary completion Investigational Study of Delayed Release Metformin Registry record

    Expected 2023-12-01; that period ended on 2023-12-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04854512

  81. Study completion Innovative Technologies for the Treatment of Pulmonary and Heart Failure Registry record

    Expected 2023-12-01; that period ended on 2023-12-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05090930

  82. Study start Effect of Empagliflozin and Dulaglutide on MAFLD in Patients With T2D Registry record

    Expected 2023-12-01; that period ended on 2023-12-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05140694

  83. Study completion Clinical Of Plain Balloon Dilatation Combined Stent Versus Endovascular Debulking Combined Drug-coated Balloon to Treat Arteriosclerosis Occlusive Disease of Lower Extremity Registry record

    Expected 2023-12-01; that period ended on 2023-12-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05158257

  84. Study completion Olive Leaf Extracts in the Control of Cardiovascular Risk Registry record

    Expected 2023-12-01; that period ended on 2023-12-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05297110

  85. Study completion Study of the Safety and Efficacy of Roxadustat in the Treatment of Heart Failure With Chronic Kidney Disease and Anemia Registry record

    Expected 2023-12-01; that period ended on 2023-12-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05691257

  86. Study start Prophylactic Permanent Pacemaker in Patients With Right Bundle Branch Block Undergoing Transcatheter Aortic Valve Implantation Registry record

    Expected 2023-12-01; that period ended on 2023-12-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05889208

  87. Study start Medical Monitoring of Older Adults Patients After Discharged From Heart Failure Hospitalization Registry record

    Expected 2023-12-01; that period ended on 2023-12-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06018532

  88. Study start The Safety and Efficacy of Carotid Body Modulation Therapy in Hypertensive Patients by External Ultrasonic Micro-bubble Registry record

    Expected 2023-12-01; that period ended on 2023-12-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06116357

  89. Study completion Coronary Rotational Atherectomy Elective vs. Bailout in Severely Calcified Lesions and Chronic Renal Failure Registry record

    Expected 2023-12-04; that period ended on 2023-12-04.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05353946

  90. Study completion Remote Ischemic Conditioning for the Treatment of Stroke-related Insomnia Registry record

    Expected 2023-12-13; that period ended on 2023-12-13.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05289518

  91. Primary completion Remote Ischemic Conditioning for the Treatment of Stroke-related Insomnia Registry record

    Expected 2023-12-13; that period ended on 2023-12-13.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05289518

  92. Study start Efficacy and Safety of Finerenone vs. Spironolactone in Patients With Primary Aldosteronism Registry record

    Expected 2023-12-16; that period ended on 2023-12-16.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06164379

  93. Study start Evaluation of the Safety and Efficacy of SGLT2 Inhibitors in Pre-diabetic Patients Registry record

    Expected 2023-12-20; that period ended on 2023-12-20.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05914857

  94. Primary completion A 16 Week Study of HRS-7535 in Adults With Type 2 Diabetes Mellitus Registry record

    Expected 2023-12-21; that period ended on 2023-12-21.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05759897

  95. Study completion Use of a Novel Artificial Intelligence Assisted Platform to Assess Optimal Dosing and Treatment Strategy of Erythropoiesis-stimulating Agents (ESA) in Hemodialysis Patients Registry record

    Expected 2023-12-23; that period ended on 2023-12-23.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05032651

  96. Primary completion Use of a Novel Artificial Intelligence Assisted Platform to Assess Optimal Dosing and Treatment Strategy of Erythropoiesis-stimulating Agents (ESA) in Hemodialysis Patients Registry record

    Expected 2023-12-23; that period ended on 2023-12-23.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05032651

  97. Primary completion Improving the Criteria for Selecting Patients for Primary Prevention of Sudden Cardiac Death by Arrhythmic Risk Stratification Registry record

    Expected 2023-12-29; that period ended on 2023-12-29.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05539898

  98. Study completion Treatment of Post-STEMI Left Ventricular Thrombus With Optimized Anticoagulant Registry record

    Expected 2023-12-30; that period ended on 2023-12-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03764241

  99. Primary completion DENEX Renal Denervation in Patients With Hypertension on no Antihypertensive Medications Registry record

    Expected 2023-12-30; that period ended on 2023-12-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04535050